Our people are our pride, helping companies resonate with their customers for 20+ years. 

About Us
Key Facts
Leadership
Insights
News
Trust Center

 

Harness the Lionbridge Lainguage Cloud to support your end-to-end localization and content lifecycle

Lainguage Cloud™ Platform
Connectivity
Translation Community
Workflow Technology
Smairt Content™
Smairt MT™
Smairt Data™
Language Quality
Analytics

SELECT LANGUAGE:

A faint circle of orange lines radiating outward.

The Unique Language Challenges of IVDs and the EU IVDR

How classification and location impact regulatory requirements

When the EU MDR went into application in 2021, Lionbridge published a white paper on language requirements under this new regulatory reform. With the EU IVDR Date of Application, 26 May 2022, approaching, we continue to examine the impact of regulatory language requirements on life sciences companies. 

Under the MDR, language has become an increasingly important and challenging activity in the European market. We continue to recommend manufacturers be aware of three important language levels in the EU: a Union level, a national level, and a device level. In this new white paper, we turn our attention to in vitro diagnostics and some of the unique language challenges of this specific type of medical devices.

The cover of a whitepaper about language requirements for the EU IVDR.

To Download The Complete Whitepaper, Please Enter Your Details Below

 

 

  • #regulated_translation_localization
  • #life_sciences
  • #whitepaper
linkedin sharing button

Lionbridge
AUTHOR
Lionbridge